144 related articles for article (PubMed ID: 17904084)
1. Prevention of venous thromboembolism, recurrent stroke, and other vascular events after acute ischemic stroke: the role of low-molecular-weight heparin and antiplatelet therapy.
Sherman DG
J Stroke Cerebrovasc Dis; 2006; 15(6):250-9. PubMed ID: 17904084
[TBL] [Abstract][Full Text] [Related]
2. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
Haas S
Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation in acute ischaemic stroke: deep vein thrombosis prevention and long-term stroke outcomes.
Lensing AW
Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S123-7. PubMed ID: 10493241
[TBL] [Abstract][Full Text] [Related]
7. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
Hull RD; Pineo GF
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
[TBL] [Abstract][Full Text] [Related]
8. Thromboprophylaxis and early antithrombotic therapy in patients with acute ischemic stroke and cerebral venous and sinus thrombosis.
Busch M; Masuhr F
Eur J Med Res; 2004 Apr; 9(4):199-206. PubMed ID: 15210400
[TBL] [Abstract][Full Text] [Related]
9. Economic impact of enoxaparin after acute ischemic stroke based on PREVAIL.
Pineo G; Lin J; Stern L; Subrahmanian T; Annemans L
Clin Appl Thromb Hemost; 2011 Apr; 17(2):150-7. PubMed ID: 21159705
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary embolism in medical patients: improved diagnosis and the role of low-molecular-weight heparin in prevention and treatment.
Merli GJ
J Thromb Thrombolysis; 2004 Oct; 18(2):117-25. PubMed ID: 15789178
[TBL] [Abstract][Full Text] [Related]
12. Warfarin versus low-molecular-weight heparin therapy in cancer patients.
Zacharski LR; Prandoni P; Monreal M
Oncologist; 2005 Jan; 10(1):72-9. PubMed ID: 15632254
[TBL] [Abstract][Full Text] [Related]
13. Reviparin sodium clivarine: a review of its therapeutic use.
Gore M; Kelkar P; Rege N; Ross C
J Indian Med Assoc; 2004 Oct; 102(10):589-90, 592. PubMed ID: 15887830
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated thrombosis: focus on extended therapy with dalteparin.
Bick RL
J Support Oncol; 2006 Mar; 4(3):115-20. PubMed ID: 16553136
[TBL] [Abstract][Full Text] [Related]
15. The pharmacoeconomics of deep vein thrombosis treatment.
Shorr AF
Am J Med; 2007 Oct; 120(10 Suppl 2):S35-41. PubMed ID: 17916458
[TBL] [Abstract][Full Text] [Related]
16. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
17. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
18. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulants in the treatment of deep vein thrombosis.
Merli G
Am J Med; 2005 Aug; 118 Suppl 8A():13S-20S. PubMed ID: 16125510
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.
Vergouwen MD; Roos YB; Kamphuisen PW
Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]